Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000257109 | SCV000324669 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 2 | 2016-10-18 | reviewed by expert panel | curation | Variant allele predicted to encode a truncated non-functional protein. |
Consortium of Investigators of Modifiers of BRCA1/2 |
RCV000257109 | SCV000327900 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 2 | 2015-10-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV005054188 | SCV005687986 | pathogenic | not provided | 2024-07-30 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Truncating variants in this gene are considered pathogenic by a well-established clinical consortium and/or database; Observed in one family in a report summarizing BRCA2 pathogenic variants identified in European and North American populations, but specific clinical details were not provided (PMID: 29446198); Not observed at significant frequency in large population cohorts (gnomAD); Also known as 8706C>G; This variant is associated with the following publications: (PMID: 29446198) |